Post by
subaru1i on Oct 24, 2023 2:19pm
Pfizer-LABS: 1 winner so far out of the 20+ strong clinical
trials, "many of them in late stage". Many more on the way. Pfizer-Arena can only purchase from LABS and hence LABS CEO..."traditional global pharmaceutical partner".
You can challenge me but you will end up looking like the fool, Motley or othewise.
Key questions for this upcoming CC:
1) Has LABS completed their "plan to generate cash in the near term" or is that still in progress?
2) Does the expand strategic manufacturing agreement with Avicanna involve new products?
In the Monday announcement, Roche also said it would obtain an option to collaborate with Pfizer on a new inflammatory bowel disease drug.
Comment by
subaru1 on Oct 25, 2023 9:38am
Medpharm has never confirmed any winner yet. if so show us the news and the name of the product.
Comment by
Starkicker on Oct 25, 2023 11:31am
Can you elaborate on the term "partner"? If LABS has the only certification for APIs and any drugs made with cannabis extractions have to be purchased through LABS as you stated, be it Pfizer, Tilray, Apotex, or whoever, then I don't see a partnership being a financial advantage any more than any other client if the model is white label APIs.